Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NUTX
NUTX logo

NUTX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nutex Health Inc (NUTX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
109.280
1 Day change
3.50%
52 Week Range
193.070
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Nutex Health Inc (NUTX) is not a strong buy at this time for a beginner investor with a long-term horizon. The company's financial performance has significantly declined, and there are no positive trading signals or catalysts to support immediate investment. Holding off on this stock for now is recommended.

Technical Analysis

The MACD is above 0 and positively contracting, indicating mild bullish momentum. RSI is neutral at 45.505, and moving averages are converging, showing no clear trend. Key support is at 96.302, and resistance is at 110.474. Overall, the technical indicators suggest a neutral stance.

Positive Catalysts

  • NULL. No recent news or significant trading trends from insiders or hedge funds.

Neutral/Negative Catalysts

  • The company's financial performance in Q4 2025 shows a significant decline in revenue (-41.12% YoY), net income (-80.79% YoY), EPS (-82.47% YoY), and gross margin (-44.67% YoY). No recent news or positive sentiment to counterbalance these declines.

Financial Performance

In Q4 2025, Nutex Health Inc reported a sharp decline in financial metrics: Revenue dropped to $151.68M (-41.12% YoY), Net Income fell to $11.83M (-80.79% YoY), EPS dropped to 1.56 (-82.47% YoY), and Gross Margin decreased to 30.42 (-44.67% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target changes available.

Wall Street analysts forecast NUTX stock price to rise
2 Analyst Rating
Wall Street analysts forecast NUTX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 105.580
sliders
Low
230
Averages
265
High
300
Current: 105.580
sliders
Low
230
Averages
265
High
300
Maxim
Maxim
Buy
downgrade
$225 -> $205
AI Analysis
2025-08-26
Reason
Maxim
Maxim
Price Target
$225 -> $205
AI Analysis
2025-08-26
downgrade
Buy
Reason
Maxim lowered the firm's price target on Nutex Health to $205 from $225 and keeps a Buy rating on the shares. On August 14th, the company filed an NT 10-Q notification of inability to timely file its 10-Q for the three months ended 6/30/25, due to the incorrect accounting classification of certain non-cash obligations, the analyst tells investors in a research note. The firm views the accounting restatements, arbitration dynamics, and lawsuits against Nutex's primary arbitration vendor, HaloMD, as potential headwinds to the stock price, Maxim added.
Maxim
Maxim
Buy
maintain
$100 -> $225
2025-05-20
Reason
Maxim
Maxim
Price Target
$100 -> $225
2025-05-20
maintain
Buy
Reason

People Also Watch